Addex Therapeutics (ADXN)

Addex Therapeutics (ADXN) Income Statement


Addex Therapeutics Income Statement

Last quarter (Q4 2022), Addex Therapeutics's total revenue was SFr.―, a decrease of -100.00% from the same quarter last year. In Q4, Addex Therapeutics's net income was SFr.―. See Addex Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
SFr. 830.01KSFr. 1.42MSFr. 2.92MSFr. 3.61MSFr. 2.76MSFr. 6.04M
Cost of Revenue
-SFr. -21.97M----
Gross Profit
-SFr. 1.42M----
Operating Expense
SFr. 17.85MSFr. 22.28MSFr. 18.42MSFr. 15.86MSFr. 17.37MSFr. 7.47M
Operating Income
SFr. -17.02MSFr. -20.86MSFr. -15.51MSFr. -12.24MSFr. -14.60MSFr. -1.43M
Net Non Operating Interest Income Expense
SFr. -76.06KSFr. 29.25KSFr. -57.69KSFr. -34.20KSFr. -91.64KSFr. -134.31K
Other Income Expense
SFr. -54.79KSFr. -22.52KSFr. 211.69KSFr. -581.13KSFr. -84.80KSFr. -85.87K
Pretax Income
SFr. -17.15MSFr. -19.53MSFr. -15.35MSFr. -12.86MSFr. -14.78MSFr. -1.64M
Tax Provision
--SFr. 0.00SFr. 0.00SFr. 0.00SFr. 0.00
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
SFr. -17.15MSFr. -19.53MSFr. -15.35MSFr. -12.86MSFr. -14.78MSFr. -1.64M
Basic EPS
SFr. -2.04SFr. -0.46SFr. -2.70SFr. -2.88SFr. -3.36SFr. -0.42
Diluted EPS
SFr. -2.04SFr. -0.46SFr. -2.70SFr. -2.88SFr. -3.36SFr. -0.42
Basic Average Shares
SFr. 12.56MSFr. 45.18MSFr. 5.69MSFr. 4.45MSFr. 4.40MSFr. 3.88M
Diluted Average Shares
SFr. 12.56M-SFr. 5.69MSFr. 4.45MSFr. 4.40MSFr. 3.88M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
SFr. 10.96K-SFr. 16.00KSFr. 12.00KSFr. 0.00SFr. 45.00K
Total Expenses
SFr. 17.85MSFr. 313.26KSFr. 18.42MSFr. 15.86MSFr. 17.37MSFr. 7.47M
Net Income From Continuing And Discontinued Operation
SFr. -17.15MSFr. -19.53MSFr. -15.35MSFr. -12.86MSFr. -14.78MSFr. -1.64M
Normalized Income
SFr. -17.10M-SFr. -15.56MSFr. -12.28MSFr. -14.70MSFr. -1.56M
Interest Expense
SFr. 79.96K-SFr. 63.01KSFr. 69.50KSFr. 128.52KSFr. 134.31K
SFr. -17.07MSFr. -19.56MSFr. -15.29MSFr. -12.79MSFr. -14.65MSFr. -1.51M
SFr. -16.83MSFr. -19.25MSFr. -14.94MSFr. -12.41MSFr. -14.32MSFr. -1.51M
Currency in CHF

Addex Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis